Dramatic decrease in fluoroquinolones in the pediatric population in KoreaSHIN, Ju-Young; MI HEE KIM; SUN MI SHIN et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 12, pp 1320-1324, issn 1053-8569, 5 p.Article

Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrelHANATANI, T; SAI, K; KAWAKAMI, J et al.Journal of clinical pharmacy and therapeutics (Print). 2014, Vol 39, Num 4, pp 361-367, issn 0269-4727, 7 p.Article

Analysis of Pharmaceutical Safety-Related Regulatory Actions in Japan: Do Tradeoffs Exist Between Safer Drugs and Launch Delay?YAMADA, Toru; KUSAMA, Makiko; HIRAI, Yuka et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 12, pp 1976-1985, issn 1060-0280, 10 p.Article

A critical review of methods to evaluate the impact of FDA regulatory actionsBRIESACHER, Becky A; SOUMERAI, Stephen B; FANG ZHANG et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 9, pp 986-994, issn 1053-8569, 9 p.Article